“US FDA inspection of the Company’s Somerset, New Jersey (US) facility. The USFDA has concluded an inspection at the Company’s wholly owned subsidiary Novel Laboratories, Inc., based in Somerset, NJ. The inspection commenced on March 7, 2020 and concluded on March 30, 2022.The inspection closed with thirteen observations.,” Lupin said in a statement to stock exchanges.
